Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GS-9667, a selective and partial agonist of the A(1) adenosine receptor (AR), represents an effective therapy for Type 2 diabetes (T2DM) and dyslipidemia via lowering of free fatty acids (FFA).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 133.00 | |
5 mg | In stock | $ 320.00 | |
10 mg | In stock | $ 470.00 | |
25 mg | In stock | $ 772.00 | |
50 mg | In stock | $ 1,080.00 | |
100 mg | In stock | $ 1,460.00 | |
500 mg | In stock | $ 2,920.00 |
Description | GS-9667, a selective and partial agonist of the A(1) adenosine receptor (AR), represents an effective therapy for Type 2 diabetes (T2DM) and dyslipidemia via lowering of free fatty acids (FFA). |
In vivo | In the single ascending dose study, healthy, non-obese, and obese subjects received GS-9667 (30-1,800 mg; oral; single dose). In the multiple, ascending dose study, healthy, obese subjects received GS-9667 (600-2,400 mg QD, 1,200 mg BID, or 600 mg QID) for 14 days. Doses of GS-9667 ≥300 mg caused dose-dependent reductions in FFA levels that were reproducible over 14 days without evidence of desensitization or rebound. All doses were well tolerated. GS-9667 was rapidly absorbed and distributed; Steady-state concentrations were achieved within 3-5 days. The A(1) AR partial agonist GS-9667 reduced plasma FFA, exhibited linear kinetics, and was well-tolerated in healthy non-obese and obese subjects.[1] |
Synonyms | CVT-3619, CVT 3619 |
Molecular Weight | 461.51 |
Formula | C21H24FN5O4S |
CAS No. | 618380-90-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/mL (119.17 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GS-9667 618380-90-8 GPCR/G Protein Neuroscience Adenosine Receptor CVT3619 CVT-3619 CVT 3619 GS9667 GS 9667 inhibitor inhibit